A Novel Approach for Producing Lentiviruses That Are Limited to a Single Cycle of Infection
- 1 November 2004
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 78 (21) , 11715-11725
- https://doi.org/10.1128/jvi.78.21.11715-11725.2004
Abstract
We have devised a novel approach for producing simian immunodeficiency virus (SIV) strains and, potentially, human immunodeficiency virus type 1 (HIV-1) strains that are limited to a single cycle of infection. Unlike previous lentiviral vectors, our single-cycle SIV is capable of expressing eight of the nine viral gene products and infected cells release immature virus particles that are unable to complete subsequent rounds of infection. Single-cycle SIV (scSIV) was produced by using a two-plasmid system specifically designed to minimize the possibility of generating replication-competent virus by recombination or nucleotide reversion. One plasmid carried a full-length SIV genome with three nucleotide substitutions in the gag-pol frameshift site to inactivate Pol expression. To ensure inactivation of Pol and to prevent the recovery of wild-type virus by nucleotide reversion, deletions were also introduced into the viral pol gene. In order to provide Gag-Pol in trans , a Gag-Pol-complementing plasmid that included a single nucleotide insertion to permanently place gag and pol in the same reading frame was constructed. We also mutated the frameshift site of this Gag-Pol expression construct so that any recombinants between the two plasmids would remain defective for replication. Cotransfection of both plasmids into 293T cells resulted in the release of Gag-Pol-complemented virus that was capable of one round of infection and one round of viral gene expression but was unable to propagate a spreading infection. The infectivity of scSIV was limited by the amount of Gag-Pol provided in trans and was dependent on the incorporation of a functional integrase. Single-cycle SIV produced by this approach will be useful for addressing questions relating to viral dynamics and viral pathogenesis and for evaluation as an experimental AIDS vaccine in rhesus macaques.Keywords
This publication has 52 references indexed in Scilit:
- Cytolysis by CCR5-Using Human Immunodeficiency Virus Type 1 Envelope Glycoproteins Is Dependent on Membrane Fusion and Can Be Inhibited by High Levels of CD4 ExpressionJournal of Virology, 2003
- Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif proteinNature, 2002
- The Major Human Immunodeficiency Virus Type 2 (HIV-2) Packaging Signal Is Present on All HIV-2 RNA Species: Cotranslational RNA Encapsidation and Limitation of Gag Protein Confer SpecificityJournal of Virology, 2001
- Selective Transcription and Modulation of Resting T Cell Activity by Preintegrated HIV DNAScience, 2001
- Maintenance of the Gag/Gag-Pol Ratio Is Important for Human Immunodeficiency Virus Type 1 RNA Dimerization and Viral InfectivityJournal of Virology, 2001
- Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4 + T CellsScience, 1999
- Recombinant Simian Immunodeficiency Virus Expressing Green Fluorescent Protein Identifies Infected Cells in Rhesus MonkeysAIDS Research and Human Retroviruses, 1999
- Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques.The Journal of Experimental Medicine, 1996
- Construction andIn VitroProperties of SIVmacMutants with Deletions in "Nonessential" GenesAIDS Research and Human Retroviruses, 1994
- Characterization of ribosomal frameshifting in HIV-1 gag-pol expressionNature, 1988